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Colloidal quantum dots (QDs) are now commercially available in a biofunctionalized form, and Fo¨rster resonance energy transfer
(FRET) between bioconjugated dots and fluorophores within the visible range has been observed. We are particularly interested in
the far-red region, as from a biological perspective there are benefits in pushing to ∼700 nm to minimize optical absorption (ABS)
within tissue and to avoid cell autofluorescence. We report on FRET between streptavidin- (STV-) conjugated CdTe quantum dots,
Qdot705-STV, with biotinylated DY731-Bio fluorophores in a donor-acceptor assay. We also highlight the changes in DY731-Bio
absorptivity during the streptavidin-biotin binding process which can be attributed to the structural reorientation. For fluores-
cence beyond 700 nm, diﬀerent alloy compositions are required for the QD core and these changes directly aﬀect the fluorescence
decay dynamics producing a marked biexponential decay with a long-lifetime component in excess of 100 nanoseconds. We com-
pare the influence of the two QD relaxation routes upon FRET dynamics in the presence of DY731-Bio.
Copyright © 2007 E. Z. Chong et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Fo¨rster (or fluorescence) resonance energy transfer was first
explored in the 1920s [1] and is increasingly gaining the
attention of multidisciplinary researchers. FRET is a tech-
nique widely used in probing the conformational changes of
biomolecules, examining the structural constitution of a tar-
geted cell and monitoring intracellular processes and many
other in vivo biological applications [2]. The main attraction
of FRET is its sensitivity to very small spatial changes, typi-
cally in the nanometer range.
FRET is based on the near field interaction between two
molecules (dipoles) in very close proximity, at a distance
much smaller than the fluorescence wavelength [3, 4]. The
excited state energy of the donor molecule can be trans-
ferred to the acceptor molecule in the ground state if there
is a considerable overlap between the donor emission and
the acceptor absorption. In the past, a variety of organic
fluorescent labels were used as probes in FRET measure-
ments [3–5]. However, photobleaching eﬀects have impaired
their function as reliable fluorescent markers especially in
single-molecule spectroscopic applications. With the discov-
ery of new robust fluorescent material such as semiconduc-
tor quantum dots, the possibility of photobleaching the inor-
ganic markers over extended excitation is no longer an issue.
QDs are well known for their photostability, high quantum
yield (QY), broad absorption spectrum, and narrow emis-
sion spectrum [6–8]. In contrast to the standard organic
dyes, these favourable features provide a new route to op-
tically pump diﬀerent size QDs using the same photoexcita-
tion energy, thus promoting multicolour microscopic imag-
ing. The specific application area which we seek to address
is in vitro cell cycle and cell lineage studies. In this context
we have confirmed that there is no discernible toxic eﬀect of
core/shell QDs on the cells over typical analysis period of 1–5
days which corroborates the fact that the release of free ions
from the core lattice is largely obviated by the surface passi-
vation [9]. Furthermore, with the advent of the commercial
core-shell QDs, a variety of emissions that cover the visible
and the infrared spectra are readily available. Therefore, in
view of the superior photostability, the biocompatibility and
the wide selection of commercial core/shell QDs, the poten-
tial of QDs as fluorescent labels is very promising.
In this work, we explored the potential of far-red
CdTe/ZnS core-shell Qdot705 (Invitrogen) as an eﬃcient
donor in a FRET assay. From the bioimaging perspective,
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this avoids the detection of autofluorescence, allows the us-
age of red excitation which has greater depth of penetra-
tion into targeted tissue, and facilitates multiphoton absorp-
tion/excitation. From a material point of view, the compo-
sitional change from selenide to telluride in Qdot705 also
makes it an interesting experimental test subject. Broader
emission/absorption spectra and a fluorescence decay life-
time well in excess of 100 nanoseconds at room tempera-
ture were seen. In our QD FRET investigation, biotinylated
DY731-Bio fluorophores with an absorption peak at 720 nm
were self-assembled onto Qdot705-STVs that emit at 705 nm
using a streptavidin-biotin binding mechanism in the similar
conjugation route as that in [10, 11]. Due to the strong spec-
tral overlap between Qdot705-STV emission and DY731-Bio
absorption, FRET signatures were detected in the steady state
and also in the time domain spectroscopic measurements.
2. MATERIALS AND METHODS
2.1. DY731-Bio-STV preparation
1 mg of streptavidin powder (Sigma-Aldrich, Dorset, UK)
was dissolved in 100 μL phosphate buﬀered saline (PBS
0.01 M, pH 7.4) to make∼170 μM streptavidin solution. 5 μL
of the solution was added to 400 μL of 2.5 μM DY731-Bio to
give a loading ratio of 1 with respect to DY731-Bio. As a re-
sult, the total biotin binding sites outnumbered DY731-Bio.
Hence, only streptavidin bound DY731-Bio were generated.
The steady-state absorption profile of DY731-Bio-STV bio-
complex was recorded with a UV/Vis/NIR Jasco V570 spec-
trometer (Tokyo, Japan) for determining DY731-Bio-STV
molar extinction coeﬃcient.
2.2. Qdot705-STV and DY731-Bio mixture by titrations
10 μL of 1 μM Qdot705-STV stock (Invitrogen, Calif, USA)
was dissolved in 400 μL PBS (pH 7.4) in a 10 mm optical path
cell. 2 μL of 30 μM DY731-Bio (MoBiTec, Go¨ttingen, Ger-
many) was first dispensed into the QD solution and then fol-
lowed by 10 successive titrations of 4 μL DY731-Bio. Steady-
state photoluminescence (PL) measurements were taken af-
ter each titration using a Varian Cary Eclipse fluorimeter
(Palo Alto, Calif, USA). For comparison, identical proce-
dures were repeated for control experiments which involved
DY731-Bio without the presence of Qdot705-STV.
2.3. Qdot705-STV-DY731-Bio conjugates preparation
5 separate PBS diluted Qdot705-STV solutions (220 μL,
∼90 nM) were mixed with increasing amount (4 μL to
200 μL) of 30 μM DY731-Bio to produce Qdot705-STV-
DY731-Bio donor-acceptor assay with diﬀerent labelling ra-
tios. It is estimated that a Qdot705-STV is chemically cou-
pled to 5–10 streptavidin [12]. As streptavidin is a tetrameric
protein, approximately 20–40 biotinylated molecules which
include DY731-Bio can be arrayed around a single Qdot705-
STV. The samples were left to sit at room temperature for
15 minutes. By ultrafiltration with Microcon YM50 spin col-
umn (Millipore, Billerica, Mass, USA), the unbound DY731-
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Figure 1: Schematic diagram of Qdot705-STV and DY731-Bio in
self-assembled assay where energy can be transferred nonradiatively
from QD to DY731-Bio upon excitation.
Bio (molecular weight, MW of ∼1 kDa) were separated from
the conjugated pairs. The column with cutoﬀ MW of 50 kDa
was spun at a centrifugal speed of 2000 × g three times for
20 minutes per wash. The collected conjugates were then dis-
solved in 100 μL PBS in 10 mm path length cuvette for time-
resolved PL measurements. The average numbers of DY731-
Bio per Qdot705-STV were estimated by steady-state absorp-
tion using a UV/Vis/NIR Jasco V570 spectrometer in ac-
cordance to the molar extinction coeﬃcient at 663 nm for
DY731-Bio-STV.
2.4. Steady-state absorption and
photoluminescence measurements
Steady-state absorptions of Qdot705-STV, DY731-Bio,
DY731-Bio-STV and Qdot705-STV-DY731-Bio in PBS
(pH 7.4) were measured using a UV/Vis/NIR Jasco V570
spectrometer. Ensemble photoluminescence spectra were
recorded with a Varian Cary Eclipse fluorimeter. To mea-
sure the photoluminescence spectrum of DY731-Bio,
680 nm excitation was chosen. However, the excitation
was set to 425 nm for all FRET experiments in order to
reduce the direct excitation of DY731-Bio fluorophores. All
measurements were performed under ambient conditions.
2.5. Time-resolved photoluminescence measurements
Qdot705-STV-DY731-Bio samples (from Section 2.3) were
photoexcited using a Ti:Sapphire laser (Coherent, Santa
Clara, Calif, USA) with a repetition rate of 1.1 MHz in or-
der to achieve a longer time window for detecting rather long
lived Qdot705-STV photoluminescence. The laser was tuned
to 850 nm and was frequency doubled to 425 nm so that di-
rect excitation of DY731-Bio was kept to a minimum. The
temporal behaviour of Qdot705-STV in a donor-acceptor as-
sembly was investigated with a Hamamatsu C5680 universal
streak camera system (Japan). The photoluminescence of dot
ensemble was spectrally filtered using a 700 nm shortpass fil-
ter to cutoﬀ unwanted DY731-Bio fluorescence and a 630 nm
longpass filter to attenuate any scattered laser. The acquisi-
tion of time-resolved photoluminescence was processed us-
ing high-performance digital temporal analyser (HPD-TA)
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Figure 2: Normalised absorption and photoluminescence spectra
of Qdot705-STV, DY731-Bio, and DY731-Bio-STV.
software (Hamamatsu, Japan). All measurements were con-
ducted under ambient environmental conditions.
3. RESULTS
3.1. Steady-state spectral measurements
3.1.1. Qdot705-STV and DY731-Bio
As shown in Figure 2, Qdot705-STV sample exhibits a broad,
continuous absorption spectrum with no pronounced ex-
citonic peak being resolved. The bulk-like spectrum is due
to the relative large size variation in the Qdot705-STV en-
semble which have a mean diameter of ∼20 nm [12]. These
QDs fluoresce at 705 nm with a full width at half maxi-
mum (FWHM) of 70 nm (-- in Figure 2). The FWHM
of Qdot705-STV emission is approximately 3 times broader
than that of the commercial CdSe/ZnS Qdots. The inhomo-
geneous size distribution is likely to be the reason behind the
broad photoluminescence spectrum, however, the crystalline
geometry and the lattice defects can also be the cofactors to
the line width broadening [13].
Unlike Qdot705-STV, pure DY731-Bio have a narrow
absorption spectrum that peaks at 720 nm with a weaker
secondary absorption at 660 nm. This strongly coincides
with the photoluminescence of Qdot705-STV which spreads
across the absorption band of DY731-Bio. However, the
absorptivity was modified when DY731-Bio were attached
to streptavidin, as depicted in Figure 2. The 660 nm ab-
sorption strength rose above that of 720 nm peak. This
is possibly due to the conformational changes in bound
DY731-Bio molecules. The molar extinction coeﬃcients
of DY731-Bio-STV at respective 660 nm and 720 nm were
found to be 100 000 M−1cm−1 and 70 000 M−1cm−1 instead
of 50 000 M−1cm−1 and 120 000 M−1cm−1 for pure DY731-
Bio.
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Figure 3: Spectra A are the composite photoluminescence of the
Qdot705-STV and DY731-Bio mixtures in a series of DY731-Bio
titrations. Spectra B are the control photoluminescence of pure
DY731-Bio solutions with the equal molar concentration of DY731
as that in the former mixtures. An expanded view of the control
spectra is shown in the inset.
The strong overlap between the DY731-Bio absorption
and the Qdot705-STV photoluminescence favours the non-
radiative energy transfer within the donor-acceptor assay.
With the large Stokes shift (∼30 nm), DY731-Bio are spec-
trally well separated from Qdot705-STV and hence, the
composite photoluminescence spectrum of a mixed donor-
acceptor ensemble can be resolved and deconvoluted into re-
spective spectra for further quantitative FRET analysis.
3.1.2. Qdot705-STV and DY731-Bio mixture by titration
Successive titrations with 30 μM DY731-Bio solution resulted
in the progressive quenching of Qdot705-STV photolumi-
nescence. Initially, the fluorescence signal at 705 nm dropped
abruptly but then gradually levelled oﬀ after a total of∼26 μL
DY731-Bio have been dispensed into the QD solution. Since
the optical densities in the first few titrations (2 μL-22 μL)
were below 0.2, the luminescence quenching in Qdot705-
STV was primarily attributed to FRET. The reabsorption of
Qdot705-STV photoluminescence by DY731-Bio was antic-
ipated to be less eﬀective. In concomitant with the quench-
ing of Qdot705-STV fluorescence, a systematic enhancement
of DY731-Bio photoluminescence was detected as shown in
Figure 3(A) with the appearance of a 750 nm peak. The en-
hanced fluorescence of DY731-Bio in the mixture was many
times more intense than the control signal of pure DY731-
Bio (see the inset of Figure 3) as the absorption of the so-
lution was dominated by the strong optical interaction with
the QD excitons at the excitation wavelength of 425 nm. The
quenching of Qdot705-STV emission and the concurrent
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Figure 4: The scattered plot represents the FRET eﬃciency as a
function of DY731-Bio to Qdot705-STV molar concentration ra-
tio of nonfiltered mixture. The eﬃciency calculated is based on the
extracted Qdot705-STV spectra (from Spectra A in Figure 3) shown
in the inset.
enhancement of DY731-Bio emission signify the occurrence
of FRET from the photoexcited Qdot705-STV donors to the
ground-state DY731-Bio acceptors.
Since FRET theory is formulated based on proximal
dipole-dipole interaction, the excited QDs were generalised
as the oscillating dipoles because of the strong electron-hole
wavefunction overlap in the core and the weak carrier tun-
nelling into the wide band gap ZnS shell [14]. FRET eﬃ-
ciency was calculated in accordance to the following equa-
tion:
E = 1− FDA
FD
, (1)
where FDA is the integrated donor fluorescence in the pres-
ence of the acceptor and FD is the integrated donor fluo-
rescence alone. As the equation is only dependent upon the
changes of donor emission intensity with acceptor, the rele-
vant Qdot705-STV spectra were extracted from the compos-
ite spectra in Figure 3(A), provided that the spectral shape
of Qdot705-STV stayed unchanged throughout the measure-
ments. As depicted in Figure 4, despite the undesirable size,
a reasonably high-eﬃcient energy transfer (∼70%) can be
achieved by Qdot705-STV as the FRET donor since its sur-
face area is large enough to interact with multiple DY731-
Bio acceptors. However, the plot of FRET eﬃciency against
acceptor/donor ratio shows some signs of saturation when
the molar ratio exceeded 50 : 1. After the 50 : 1 molar ra-
tio, the incremental step in FRET eﬃciency for successive
DY731-Bio titrations scaled down dramatically. Unlike the
inorganic QD, the conventional organic dyes are generally
confined to single donor-acceptor pairing in a FRET assay
because of their comparatively small molecular sizes, which
in turn impose strict spatial separation condition between
the interacting donor-acceptor molecules (typically less than
100 A˚) for achieving high FRET eﬃciency.
0.1
1
N
or
m
al
iz
ed
P
L
in
te
n
si
ty
(a
.u
.)
0 50 100 150 200 250
Time (ns)
Number of bound
DY731-Bio per dot
0
5
7
12
16
20
Figure 5: Photoluminescence decay of Qdot705-STV with increas-
ing number of labelled DY731-Bio after centrifugation.
3.2. Temporal photoluminescence measurements
3.2.1. Qdot705-STV-DY731-Bio conjugates by
ultrafiltration
Due to the partial crosstalk, the Qdot705-STV emission was
spectrally separated from DY731-Bio using a 700 nm short-
pass filter. By monitoring the temporal changes in the fluo-
rescence spectrum below 700 nm, the interaction dynamics
of Qdot705-STV ensembles in the presence of bound accep-
tors were studied. As illustrated in Figure 5, with increasing
number of bound DY731-Bio from 5 to 20 per dot, the QD
fluorescence decay was progressively shortened. Henceforth,
it would appear that an additional nonradiative relaxation
pathway was introduced when DY731-Bio fluorophores were
self-assembled around Qdot705-STV: the photoexcited QD
excitons recombined at a faster rate by coupling to the ra-
diationless transitions. In view of the fact that a Qdot705-
STV can be chemically coupled up to 10 tetrameric strepta-
vidin [12], the highest elicited number of labelled DY731-
Bio per QD from the absorption measurement was relatively
low compared with the prediction that a maximum 40 bi-
otinylated biomolecules can be possibly assembled around a
Qdot705-STV. Therefore, this elucidates, in practise, the av-
erage number of streptavidin per QD maybe less than 10, and
also the obscuration of some of the binding sites due to the
compactness of large streptavidin proteins around the QD is
not unlikely.
The fluorescence decay curves shown in Figure 5 depict
a complex, multiexponential relaxation of the dots and so a
specific method of analysis must be adopted in interpreting
the data. We use a biexponential fitting that (i) is the sim-
plest approach outside of a monoexponential model and (ii)
provides a conceptual framework for interpretation relating
to QD photophysics. There are of course alternative mea-
sures that could be adopted, for example, the definition of
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Qdot705-STV labelling ratio.
an eﬀective 1/e lifetime. Our main purpose in this paper is to
highlight the complexity of the QD decay dynamics and as-
sess the ramifications of this in quantifying FRET-based anal-
yses. The fluorescence dynamic of Qdot705-STV was fitted
with the decay function:
I(t) = A1 exp
(−t
τ1
)
+ A2 exp
(−t
τ2
)
+ Z (2)
with Z as the baseline. Two distinct lifetime components were
derived from the fit. τ1 fell within 100-nanosecond range
and τ2 fell within 30-nanosecond range. We associate each
lifetime component to diﬀerent, spatially distinct excitonic
relaxation paths [15]. From the two lifetime components,
FRET eﬃciency was explicitly calculated for each dynamic
process using the equation below:
E = 1− τDA
τD
, (3)
where τDA is the donor fluorescence lifetime in the pres-
ence of the acceptors and τD is the donor fluorescence life-
time without the acceptors. Since FRET is the inverse sixth
power to R (donor-acceptor separation), it is intuitive that
the eﬃciency from spatially separated recombination paths
will diﬀer. As reflected in Figure 7, the short-lifetime com-
ponent achieved higher FRET eﬃciency as compared to that
of the long-lifetime component. In this FRET study, we were
able to obtain an approximate 46% eﬃciency from the short-
lifetime component at an average 20 bound DY731-Bio per
QD. On the contrary, the eﬃciency was merely 27% for the
long-lifetime component at the same labelling ratio. The
marked variation asserts the close proximity of the fast de-
cay pathway to the DY731-Bio acceptors.
4. DISCUSSION
Qdot705-STV is a core-shell QD coated with a layer of
amphiphilic polymer for water solubility and further sur-
face functionalized with streptavidin for biolinking purposes
[16]. Its core is made of direct gap II-VI CdTe with band gap
energy of 1.44 eV (at room temperature) [17] which coarsely
dictates the emission wavelength of QD. By surface passi-
vation with a larger band gap material like ZnS (3.54 eV
at room temperature), the quantum yield of the QDs can
be significantly enhanced by suppressing the surface states
which may arise from the lattice reconstructions at the fi-
nal stage of nucleation [6, 7, 18]. However, a perfect passi-
vation is diﬃcult to achieve due to appreciable lattice mis-
match between CdTe and ZnS. The lattice constants for CdTe
and ZnS are 4.57 A˚ and 3.81 A˚ (wurzite) [17], respectively,
which accounts for a total of 17% diﬀerence in bond length.
In comparison to the visible QDs which are typically made of
CdSe, the mismatch is less, at about 12% [6, 19]. So, the sur-
face defects are more predominant in CdTe/ZnS core-shell
QDs. The presence of carrier traps near the CdTe/ZnS in-
terface can weaken the oscillator strength of the dipole mo-
ment by decreasing the spatial overlap of the exciton wave-
function [20]. Photoexcited electrons are quickly delocalized
by surface states, but due to a reduced mobility, the heav-
ier hole is restricted to the inner core. Other factors such as
geometrical characteristics of QD (shape and size) can influ-
ence the optical absorption as well [13]. Qdot705-STV may
not experience the same quantum confinement eﬀects in all
dimensions like other commercial visible range Qdots (i.e.,
Qdot565 and Qdot585) since it adopts a slightly elongated
geometry which means that the photoinduced carriers have
greater degree of freedom compared to the symmetric spher-
ical QDs [21]. Therefore, the quantization of excited states is
less pronounced in the Qdot705-STV absorption spectrum.
Bacterial derivative streptavidin is known to have excep-
tionally high biotin binding aﬃnity (Ka ≈ 2.5 × 1013 M−1)
[22]. Lower nonspecific binding as compared to analo-
gous egg white derivative avidin is an added advantage
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in developing superior bioassays for nanosensing devices.
In this work, we study the near-field interactions in
Qdot705-STV-DY731-Bio self-assembled assay with the use
of streptavidin-biotin noncovalent linkers. With the capac-
ity of accommodating multiple bioconjugations and the
good spectral overlap between donor emission and accep-
tor absorption, FRET can occur between large QDs and bio-
quenchers [23]. In this QD FRET investigation, we were able
to achieve high FRET transfer between large Qdot705-STV
and DY731-Bio. Besides that, we also observed some dras-
tic changes in the absorption properties of DY731-Bio when
they were bound to streptavidin. The 660 nm absorbance
was much stronger than the absorbance at 720 nm. The flu-
orophore probably reoriented itself during the association
of streptavidin-biotin and hence, induced some structural
changes to accommodate the binding site. It is unlikely that
the changes in the absorption were caused by the surface
charge of streptavidin since the same spectral shift was de-
tected when DY731-Bio were dispensed in either ethanol
or PBS solvents. The analytical interpretation of the FRET-
based assay becomes more complicated if the molar extinc-
tion coeﬃcient of the acceptor is undesirably modified upon
binding. It could possibly influence the overlap integral J,
Fo¨rster distance R0 down to the theoretical FRET eﬃciency
prediction.
Strong enhancement in DY731-Bio emission due to ra-
diationless energy transfer from photoexcited Qdot705-STV
was observed. Direct excitation at 425 nm was minimal as
shown in Figure 3(B). In contrast to the DY731-Bio accep-
tor, the photoluminescence of Qdot705-STV was quenched
drastically during the initial stage of titrations when the ma-
jority of the added DY731-Bio should have attached onto QD
surface via streptavidin-biotin aﬃnity. Based on the findings
in Section 3.2, after the centrifugation with a Microcon fil-
ter device, one Qdot705-STV can bind up to 20 biotinylated
acceptors. In regard to that information, for a nonfiltered so-
lution, further titrations (between ∼20 : 1 and ∼60 : 1 molar
ratio) should only saturate the outermost surface area of the
QDs with free DY731-Bio. As a result, the diﬀused free and
the immobilised DY731-Bio were competing for FRET which
inherently led to the enhanced eﬃciency after the molar ratio
of 20 : 1. We speculate that the slow growth in the eﬃciency
after 22 μL of DY731-Bio could be the onset of eﬀective ra-
diative quenching by DY731-Bio. It is clear that Qdot705-
STV can serve as an eﬃcient donor if the interactions with
multiple acceptors are permitted.
The photoluminescence decay of a QD ensemble is mul-
tiexponential. The photophysical characteristics in QD en-
sembles have been correlated to decay-time fluctuations in
single QDs [24, 25]. Since the measurements here were taken
over an extended period of time, the intensity-dependent ef-
fect and the size dispersion in the QD ensemble have aver-
aged out the decay lifetime. The photoluminescence decay
can be considered as the collective dynamic behaviour of ex-
cited QDs. We statistically fitted the Qdot705-STV photolu-
minescence decay with discrete biexponential function. The
fitted lifetimes were significantly diﬀerent, 30 nanoseconds
and 100 nanoseconds, respectively. Due to a 17% lattice mis-
match at the core-shell interface, the formation of fast re-
sponse, carrier trapping states at the surface is highly prob-
able. These surface states provide nonradiative relaxation
pathways for the photoinduced electron-hole pairs. Since ex-
citon quenching by surface states usually occurs within sub-
nanosecond times, we attribute the fast decay to carrier trap-
ping by surface states and the slow decay to radiative recom-
bination from the band edge. Besides the QD excitonic state,
surface states can also couple to DY731-Bio excited state
for radiationless energy transfer provided that the surface-
state energy level is within the strong absorption band of
DY731-Bio. Instead of taking the amplitude-weighted mean
lifetime, FRET generated from two separate transitions were
studied independently. From Figure 7, the reduction of the
long-lifetime component was less significant than that of the
short-lifetime component with increasing conjugation ratio.
FRET from surface states was apparently more eﬃcient than
that from the band edge level. Assuming that this is due to the
R−6 relation of FRET, the results are consistent with the in-
terpretation based on the biexponential decay model that the
surface states are spatially nearer to labelled DY731-Bio and
the band edge recombination primarily occurs within the in-
ner core.
5. CONCLUSIONS
We explored the possibility of FRET in a Qdot705-
STV-DY731-Bio assembly with the application of strong
streptavidin-biotin binding aﬃnity. By careful selection, we
minimized the spectral crosstalk between QD donor and
fluorophore acceptor emissions but maximized the spectral
overlap between donor emission and acceptor absorption.
FRET was derived as the resultant of the quenching eﬀect
on QD steady-state fluorescence in stepwise DY731-Bio titra-
tions. An eﬃciency of ∼70% was easily achieved at a molar
ratio of 50 acceptors to one QD owing to QD’s large sur-
face area. We also recorded the diﬀerences in the absorptiv-
ity between DY731-Bio and DY731-Bio-STV which could be
related to the structural reorientation of fluorophores when
molecular complex was formed. However, no further struc-
tural studies were conducted to examine the conformation
of steptavidin bound DY731-Bio. Any variation in the ab-
sorption strength of conjugated acceptor can render FRET
less eﬃcient than predicted, if it is based on the optical den-
sity of the noninteracting acceptor. By size exclusion filtra-
tion, excess DY731-Bio were removed and only Qdot705-
STV-DY731-Bio were collected. We achieved ∼20 acceptors
per QD which resulted in ∼50% FRET eﬃciency. Lifetime
measurements on the Qdot705-STV-DY731-Bio assay have
further confirmed that FRET can be realized despite the un-
desirable size of QD. However, the highest eﬃciency obtain-
able is limited by the number of streptavidin attached to
Qdot705-STV.
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